Your browser doesn't support javascript.
loading
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki, Elma; Borger, Daniel K; Moaven, Nima; Stubblefield, Barbara K; Rogers, Steven A; Patnaik, Samarjit; Schoenen, Frank J; Westbroek, Wendy; Zheng, Wei; Sullivan, Patricia; Fujiwara, Hideji; Sidhu, Rohini; Khaliq, Zayd M; Lopez, Grisel J; Goldstein, David S; Ory, Daniel S; Marugan, Juan; Sidransky, Ellen.
Afiliación
  • Aflaki E; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Borger DK; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Moaven N; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Stubblefield BK; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Rogers SA; University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047, and.
  • Patnaik S; National Center for Advancing Translational Sciences.
  • Schoenen FJ; University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas 66047, and.
  • Westbroek W; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Zheng W; National Center for Advancing Translational Sciences.
  • Sullivan P; Clinical Neurocardiology Section, and.
  • Fujiwara H; Diabetic Cardiovascular Disease Center and Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Sidhu R; Diabetic Cardiovascular Disease Center and Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Khaliq ZM; Cellular Neurophysiology Unit, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
  • Lopez GJ; Section of Molecular Neurogenetics, National Human Genome Research Institute.
  • Goldstein DS; Clinical Neurocardiology Section, and.
  • Ory DS; Diabetic Cardiovascular Disease Center and Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Marugan J; National Center for Advancing Translational Sciences.
  • Sidransky E; Section of Molecular Neurogenetics, National Human Genome Research Institute, sidranse@mail.nih.gov.
J Neurosci ; 36(28): 7441-52, 2016 07 13.
Article en En | MEDLINE | ID: mdl-27413154

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glucolípidos / Trastornos Parkinsonianos / Alfa-Sinucleína / Células Madre Pluripotentes Inducidas / Neuronas Dopaminérgicas / Enfermedad de Gaucher / Glucosilceramidas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glucolípidos / Trastornos Parkinsonianos / Alfa-Sinucleína / Células Madre Pluripotentes Inducidas / Neuronas Dopaminérgicas / Enfermedad de Gaucher / Glucosilceramidas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2016 Tipo del documento: Article